Alexandria, Va. (Oct. 5, 2026) Today the American Association for the Study of Liver Diseases (AASLD) lifted the press embargo on abstracts submitted for The Liver Meeting® (TLM), Denver. Over 2,900 abstracts have been submitted to date. Within the submissions, topics cover 24 different topic areas including MASLD, Liver Transplantation, Liver Surgery, and Hepatitis B.
The supplement provides the following breakdown of the leading abstract categories:
- MASLD and MASH: 676 abstracts
- Liver Transplantation and Liver Surgery: 234 abstracts
- Portal Hypertension and Other Complications of Cirrhosis: 234 abstracts
- Alcohol-Associated Liver Diseases, Clinical and Experimental: 216 abstracts
- Hepatobiliary Neoplasia: 214 abstracts
- Hepatitis B: 204 abstracts
- Human Cholestatic and Autoimmune Liver Diseases: 201 abstracts
TLM's global reach continues to be reflected in this year's call for Abstracts, with China, India, South Korea, Japan, and Canada ranking among the top five international contributors. Overall abstract submissions are also beginning to approach pre-COVID numbers.
The final embargo for Late-Breaking Abstracts will lift on Thursday, Nov. 5, 2026, at 8:00 AM MT. For more information on AASLD’s embargo policy for TLM, please click here.
###
About AASLD
The American Association for the Study of Liver Diseases (AASLD), founded in 1950, is the leading global organization of scientists and health care professionals dedicated to advancing the science and practice of hepatology and improving liver health for all. Through cutting-edge research, professional education, practice guidance, advocacy, and collaboration, AASLD works to prevent, treat, and ultimately cure liver disease. The association supports a vibrant, multidisciplinary community committed to driving innovation and improving patient outcomes worldwide. Learn more at www.aasld.org.
About The Liver Meeting®
TLM is the premier global event in hepatology, bringing together the researchers, clinicians, advanced practice providers, specialists, and leaders shaping the future of liver care. Through cutting-edge science, practical education, and meaningful collaboration, attendees gain the knowledge and tools needed to address today's most pressing challenges in hepatology. With expert-led sessions, innovative exhibits, and unmatched networking opportunities, TLM empowers professionals across every career stage to advance patient care and research to elevate the standard of liver health worldwide. Learn more about TLM26 at www.aasld.org/tlm-26.
About HEPATOLOGY
The premier publication in the field of liver disease, HEPATOLOGY publishes original, peer-reviewed articles concerning all aspects of liver structure, function and disease. Each month, the distinguished Editorial Board monitors and selects only the best articles on subjects such as immunology, chronic hepatitis, viral hepatitis, cirrhosis, genetic and metabolic liver diseases and their complications, liver cancer, and drug metabolism. Follow the journal on X at @HEP_Journal.